The optimal way to achieve cost-effective and sustainable production of biosimilars, novel biopharmaceuticals, vaccines, and enzymes is through the efforts of R&D and the accumulation of technical talent and know-how.

As a company, we believe that synthetic biology is ready to provide optimal solutions for the problems and challenges of the biotechnology and biomedical sector.